Gene expression profiling, used within the existing framework of toxicologic assessment, promises to advance significantly the mechanistic understanding and prediction of adverse effects. To benefit fully from the opportunities offered by gene expression profiling, we must first understand the relationships between changes in gene expression and alterations in traditional toxicology parameters. The process by which gene expression changes are linked to changes in phenotype has been termed "phenotypic anchoring" ([@b8-ehp0112-001589]; [@b42-ehp0112-001589]; [@b47-ehp0112-001589]). This approach has been used successfully to identify groups of genes whose expression correlates with specific pathologic changes during griseofulvin-induced chronic liver injury ([@b11-ehp0112-001589]), renal toxicity ([@b2-ehp0112-001589]), furan-mediated hepatotoxicity ([@b14-ehp0112-001589]), and aceta-minophen-induced hepatotoxicity ([@b16-ehp0112-001589]). In the present study we used phenotypic anchoring, in conjunction with gene ontology analysis, to define the transcriptional program associated with the response of the rodent uterus to a reference estrogen and to identify groups of genes that may drive specific histologic changes.

The immature mouse uterus is a major estrogen-responsive organ and forms the basis for a reference assay of estrogenic activity of chemicals ([@b39-ehp0112-001589]). The physiologic response of the uterus to exogenous estrogens has been documented in detail ([@b6-ehp0112-001589]). The immature mouse uterus is sensitive to elevations in endogenous levels of 17β -estradiol (E~2~) that occur during puberty. E~2~ releases the immature uterus from quiescence and promotes cell proliferation and differentiation. The initial effects of E~2~ are rapid (4--6 hr) and involve the uptake of fluid resulting from hyperemia and vasodilation of uterine capillaries, which causes the uterus to swell. This phenomenon is termed "water imbibition" and increases the availability of substrates and ions required for growth. Another early event is an increase in overall levels of mRNA and protein synthesis. The uterus then enters a proliferative phase that is responsible, at least in part, for the large increase in uterine weight that occurs 16--30 hr after E~2~ exposure. Later responses mimic the changes in uterine physiology that accompany the onset of puberty and include alterations in the surface of the luminal epithelia.

Although the events described above have been characterized at the physiologic level, little is known about how E~2~, acting through the estrogen receptors ER-αand ER-β, coordinates at the molecular level the myriad cellular processes involved, despite significant progress in elucidating the molecular mechanisms by which ERs regulate gene expression *in vitro* ([@b13-ehp0112-001589]; [@b27-ehp0112-001589]; [@b28-ehp0112-001589]; [@b31-ehp0112-001589]; [@b30-ehp0112-001589]; [@b54-ehp0112-001589]). Our data reveal the transcriptional program associated with E~2~-induced uterine growth. We show that E~2~ induces a tightly coordinated transcriptional program that regulates successive and interlinked cellular processes during the uterotrophic response. Moreover, by comparing changes in gene expression with alterations in uterine weight and histology, we have identified classes of genes that may drive specific histologic changes in the uterus, including fluid uptake, coordinated cell division, and remodeling of the luminal epithelial cell layer in preparation for embryo implantation. Our data also provide novel insights into how E~2~ initiates paracrine signaling events, recruits immune and inflammatory cells, increases mRNA and protein synthesis, and suppresses apoptosis.

These data describe, at an unprecedented level of detail, how E~2~ induces organ growth and maturation and provide a paradigm for understanding the mechanisms of action of other nuclear receptors. Furthermore, this study demonstrates that analysis of the temporal associations between a chemically induced transcriptional program and the accompanying histologic changes can provide valuable insight into the relationships between gene expression changes and phenotypic alterations.

Materials and Methods
=====================

Animals
-------

Female Alpk:Ap~f~CD-1 mice (19--20 days old), weighing no more than 14 g on arrival in the laboratory, were obtained from a barriered animal breeding unit (AstraZeneca, Macclesfield, Cheshire, UK). The animals were housed five per cage in solid-bottom cages and allowed to acclimatize for 24 hr. They were allowed RM1 diet (Rat and Mouse No. 1; Special Diet Services Ltd., Witham, Essex, UK) and water ad libitum for the duration of the study. All animal experimentation described in this article was conducted in accord with accepted standards (local and national regulations) of humane animal care. Group sizes of 10 animals were used for the first two of the three replicate studies. Five animals per group were used in the third replicate study.

Uterotrophic Assays
-------------------

The mice were given a single subcutaneous injection of E~2~ (400 μg/kg) or arachis oil (AO; vehicle control) using a dosing volume of 5 mL/kg body weight. A single dose of E~2~ was used to avoid the complex transcriptional program that may result from the standard uterotrophic assay exposure regime (i.e., repeated administration on 3 consecutive days; [@b35-ehp0112-001589]). The relatively high dose level of 400 μg/kg was chosen to ensure a sustained and significant increase in blotted uterine weight during the 72-hr sampling period ([Supplemental Data, Figure 1](#SD1){ref-type="supplementary-material"}). No overt toxicity was observed during the 72-hr exposure to E~2~ (400 μg/kg). All animals were terminated at the appropriate time using an overdose of halothane (Concord Pharmaceuticals Ltd., Essex, UK) followed by cervical dislocation. Vaginal opening was recorded, and the uterus was then removed, trimmed free of fat, gently blotted, and weighed. Blotted uterine weights were analyzed by covariance with terminal body weights (SAS [@b46-ehp0112-001589]). Half of each left uterine horn was fixed in 10% formol saline and processed to paraffin wax for histologic analysis ([@b35-ehp0112-001589]). The mean thickness of the endometrial and epithelial cell layers, indicators of cellular hypertrophy, were calculated based on the assessment of 10 locations on hemotoxylin- and eosin-stained longitudinal uterine sections for each animal. All hypertrophy data were assessed for statistical significance by analysis of variance (ANOVA). The remainder of the uterus was snap frozen in liquid nitrogen and stored at −70°C for RNA extraction.

Mitotic Index
-------------

The total number of mitotic figures in each uterus section was counted, noting the tissue location, and the area of the section was measured using a KS400 image analysis system (Imaging Associates, Bicester, UK). The number of mitotic figures per square millimeter was calculated, and the frequency after administration of E~2~ was compared with the frequency seen after the administration of AO using an appropriate statistical procedure. The number of mitoses per square millimeter was considered by a fixed-effects ANOVA allowing for treatment, time, and the treatment by time interaction. Analyses were carried out using the MIXED procedure in SAS, version 8.2 (SAS [@b46-ehp0112-001589]). Contrasts within the treatment by time interaction provided estimates of differences in E~2~ and control response at each time point. These were compared statistically using a two-sided Student *t*-test based on the error mean square in the ANOVA.

Transcript Profiling and Data Analysis
--------------------------------------

Three independent biologic replicates of the entire time course study for E~2~-treated and time-matched AO-treated groups of animals were used to generate transcript profiling data and for subsequent statistical analysis. To minimize the effect of any interanimal variability, total RNA was isolated from the pooled uteri for each treatment group (*n* = 10 in the first two studies; reduced to *n* = 5 for the last study because of highly similar transcriptional responses being obtained in replicate studies 1 and 2) using RNeasy Midi kits (Qiagen Ltd., Crawley, West Sussex, UK). Biotin-labeled complementary RNAs were synthesized using the Enzo Bioarray HighYield RNA transcript labeling kit and hybridized to Affymetrix murine U74-Av2 GeneChips as described previously ([@b60-ehp0112-001589]) and in the Affymetrix GeneChip expression analysis technical manual ([@b1-ehp0112-001589]). Probe arrays were scanned and the intensities were averaged using Microarray Analysis Suite 5.0 (Affymetrix, High Wycombe, UK). The mean signal intensity of each array was globally scaled to a target signal value of 500. To select E~2~-responsive genes, each gene was subjected to a mixed-model ANOVA allowing for treatment, time, and the treatment by time interaction as fixed effects and replicate study as a random effect. The use of mixed ANOVA models for the analysis of differential gene expression in microarray experiments has been previously described ([@b5-ehp0112-001589]; [@b7-ehp0112-001589]). Analyses were carried out using the MIXED procedure in SAS, version 8.2 (SAS [@b46-ehp0112-001589]). Contrasts within the treatment by time interaction provided estimates of differences in E~2~ and control response at each time point. These were compared statistically using a two-sided Student *t*-test based on the error mean square in the ANOVA \[[Supplemental Data, Table 1](#SD1){ref-type="supplementary-material"} (<http://ehp.niehs.nih.gov/txg/members/2004/7345/supplemental.pdf>)\]. Data for genes exhibiting significant changes in expression (*p* \< 0.01, two-sided) at one or more time points were then exported into GeneSpring 6.0 (SiliconGenetics, Redwood City, CA, USA), and a data transformation (values \< 0.01 set to 0.01) and per-chip normalization (to the 50th percentile) were applied. Genes that did not have a *Present* detection call (Affymetrix) in any of the 14 treatment groups were removed from further analysis. Ratios of changes in gene expression were then calculated by normalizing each E~2~-treated sample to its corresponding time-matched vehicle (AO)-treated control. GeneChip data sets for the three independent biologic replicates were interpreted in log of ratio analysis mode, with biologic replicates being selected as a noncontinuous parameter. A total of 3,538 E~2~-responsive genes exhibiting a minimum of 1.5-fold up- or down-regulation in at least one time point were then subjected to gene tree--based hierarchical clustering (Pearson correlation). To identify genes that function in specific biologic pathways, these 3,538 genes were further filtered using functional annotations derived from the NetAffx database‚ Analysis Center ([@b22-ehp0112-001589]; <http://www.affymetrix.com/analysis/index.affx>), together with manual annotations from published literature, before hierarchical clustering using GeneSpring. Gene names used in this article (see [Appendix](#ta1-ehp0112-001589){ref-type="table"}) were derived by homology searching of nucleotide sequence databases (BLASTn; <http://www.ncbi.nih.gov/BLAST/>) using Affymetrix probe target sequences and the interrogation of NetAffx ([@b22-ehp0112-001589]) database. All genes described in the figures and text showed statistically significant alterations in expression in all three replicate studies. MIAME (Minimum Information About a Microarray Experiment)-compliant microarray data for the three independent replicate studies are available as supplementary information and have been submitted to the Gene Expression Omnibus (GEO) database (<http://www.ncbi.nlm.nih.gov/geo/>).

Quantitative Real-Time Polymerase Chain Reaction
------------------------------------------------

Uterine RNA was isolated and purified from all E~2~-treated and time-matched vehicle control groups (each consisting of pooled uteri) in all three replicate time course studies using the Qiagen RNeasy Midi kit (Qiagen). Before reverse transcription, RNA was treated with Dnase I (DNA-free kit; Ambion, Huntington, UK) to remove any contaminating genomic DNA. For each pool, 2 μg total RNA was reverse transcribed in a 25-μL reaction using SuperScript II (Invitrogen, Paisley, UK) and oligo-dT primer according to the manufacturer's instructions. Polymerase chain reaction (PCR; 25 μL) containing 2 μL first-strand cDNA (1:10 dilution), 12.5 μL of SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK), and 0.3 μM each of forward and reverse primers were run for 40 amplification cycles in an ABI PRISM 7700 Sequence Detection System (Applied Biosystems). Cycling conditions were 50°C for 2 min, 9°C for 10 min, 95°C for 15 sec, and 60°C for 1 min. All reactions were run in triplicate. Real-time (RT) PCR primers for *FOS* (5′-CTGTGGCCTCCCTGGATTTG-3′and 5′-TGAGAAGGGGCAGGGTGAAG-3′), *LTF* (5′-CGGGGGCCTTCAGACCATC-3′and 5′-CTAAAGTGACAGCAGGG AGTG-3′), and the control gene *RPB1* (5′ - GTTCTGGACCCCATTTTTGATAGGC-3′ and 5′-CAGGGGACTGGCAGGGTAACAA-3′) were designed using Primer Express software (version 1.5; Applied Biosystems) to generate amplicons within their corresponding Affymetrix probe set target sequences.

Results
=======

Histologic Changes and Increases in Uterine Weight
--------------------------------------------------

Our aim was to identify the genes and molecular networks associated with the uterotrophic response and to define the relationships between gene expression changes and histologic alterations. To this end, we gave immature female mice a single subcutaneous injection of E ~2~ (400 μg/kg) or vehicle and used DNA microarrays to measure uterine gene expression profiles at seven different times (1, 2, 4, 8, 24, 48, and 72 hr) after exposure. To facilitate the phenotypic anchoring of expression changes, we also measured blotted uterine weights and determined the average heights of the luminal epithelium and stromal endometrium for each animal. Three independent replicate experiments were carried out to allow a rigorous statistical analysis of the gene expression data (see "Materials and Methods"). We chose to use a single dose of E~2~ to avoid the complex transcriptional program that may result from the standard uterotrophic assay exposure regime in which test compound is dosed by repeated administration on 3 consecutive days ([@b35-ehp0112-001589]). This dose induced a sustained increase in blotted uterine weight that was similar in the three replicate experiments ([Figure 1A](#f1-ehp0112-001589){ref-type="fig"}). In each replicate experiment, a significant increase (*p* \< 0.01) in uterine weight was observed 4 hr after exposure to E~2~ and reached maximal levels between 24 and 72 hr ([Figure 1A](#f1-ehp0112-001589){ref-type="fig"}).

Histologic analysis of uterine sections revealed the cellular changes associated with the increase in uterine weight between 1 and 72 hr ([Figure 2A](#f2-ehp0112-001589){ref-type="fig"}). Consistent with previous reports ([@b6-ehp0112-001589]), the weight increase that occurred within 4 hr of exposure ([Figure 1A](#f1-ehp0112-001589){ref-type="fig"}) was associated with thickening of the stromal endometrium ([Figure 2B](#f2-ehp0112-001589){ref-type="fig"}) resulting from the uptake of fluid. The larger increase in uterine weight that occurred between 8 and 24 hr was due to hypertrophy and cell proliferation ([@b19-ehp0112-001589]; [@b45-ehp0112-001589]), which caused an increase in thickness of the luminal epithelium between 8 and 24 hr ([Figure 2C](#f2-ehp0112-001589){ref-type="fig"}). We conclude that the single dose of E ~2~ used induced a conventional uterotrophic response. Furthermore, the expression profiles of two classical E~2~-responsive genes, lactotransferrin (*LTF* ; [@b23-ehp0112-001589]) and the proto-oncogene *C-FOS* ([@b58-ehp0112-001589]), demonstrate that E~2~ elicited a robust transcriptional response that was similar in the three replicate experiments ([Figure 1B](#f1-ehp0112-001589){ref-type="fig"}).

Multistep Method for Analysis of Gene Expression Changes
--------------------------------------------------------

Uterine RNA from the seven time points for each of the E~2~-treated and time-matched vehicle control groups was analyzed using Affymetrix MG-U74Av2 GeneChips. A total of 42 microarray data sets were collected for the three replicate experiments. We used a multistep method to analyze the microarray gene expression data ([Figure 3A](#f3-ehp0112-001589){ref-type="fig"}). First, data were filtered and subjected to statistical analyses to identify the 3,538 genes with altered expression in E~2~-treated mice (*p* \< 0.01 and \> 1.5-fold) during at least one time point (see "Materials and Methods"). Unsupervised hierarchical clustering was then used to group these genes into co-regulated clusters ([@b44-ehp0112-001589]; [Figure 3B](#f3-ehp0112-001589){ref-type="fig"}), revealing a complex multistage transcriptional response to E~2~ in the uterus (gene clusters A--I in [Figure 3B](#f3-ehp0112-001589){ref-type="fig"}). To gain an overview of the predominant molecular functions and biologic pathways that were regulated at the transcriptional level during the uterotrophic response to E~2~, we interrogated the 3,538 E~2~-responsive genes using the GOStat gene ontology mining tool (<http://gostat.wehi.edu.au>) ([@b3-ehp0112-001589]). This approach revealed that E~2~ targets predominantly genes involved in protein metabolism, cell cycle, cell proliferation, DNA replication, RNA metabolism, mRNA transcription, and blood vessel development \[[Supplemental Data, Table 2](#SD1){ref-type="supplementary-material"} (<http://ehp.niehs.nih.gov/txg/members/2004/7345/supplemental.pdf>)\]. Next, we used a supervised clustering approach using customized gene ontology definitions (see "Materials and Methods") to identify gene functions that were predominant in each co-regulated cluster in [Figure 3B](#f3-ehp0112-001589){ref-type="fig"}. This revealed that E~2~ regulates each class of gene during a narrow window of time and suggests that E~2~ induces uterine growth and maturation by regulating successively the activities of different biologic pathways (described below). Finally, we analyzed the temporal associations between the gene expression program and alterations in uterine weight and histology to anchor the gene expression changes to alterations in uterine phenotype. These associations are described below.

Phase 1: Rapid Induction of Transcriptional Regulators and Signaling Components by E~2~
---------------------------------------------------------------------------------------

The first 4 hr of the uterotrophic response is characterized by the influx into the uterus of fluid that provides the nutrients and ions required for growth ([@b6-ehp0112-001589]). This leads to decompaction of stromal cells ([Figure 4A](#f4-ehp0112-001589){ref-type="fig"}) and thickening of the stromal endometrial layer at 4 hr ([Figure 2B](#f2-ehp0112-001589){ref-type="fig"}). This first phase of the uterotrophic response is accompanied by the rapid and transient regulation of genes encoding components of intra- and inter-cellular signaling pathways ([Figure 4B](#f4-ehp0112-001589){ref-type="fig"}) and sequence-specific transcriptional regulators ([Figure 4C](#f4-ehp0112-001589){ref-type="fig"}). Most of these genes show maximal expression between 1 and 4 hr, suggesting that the transcriptional effects of E ~2~, mediated via ER- αand ER-β, are amplified rapidly through the induction or modulation of multiple transcriptional and nontranscriptional signaling pathways.

Signaling Genes
---------------

The signaling genes rapidly up-regulated by E~2~ function in a broad array of signal transduction pathways ([Figure 4B](#f4-ehp0112-001589){ref-type="fig"}). These genes include protein kinases (*AKT, MEK1, PIM3*), growth factors (*VEGF*, *PLGF*), GTPases (*RHOC, RAB11A, DEXRAS1*), cytokine signaling proteins (*MCP1, SOCS1, SOCS3*, *WSB1, IL17R*), and a Wnt signaling factor (*WNT4*). Several E ~2~ -induced genes may act to attenuate initial signaling events (e.g., the protein phosphatase *MKP1* negatively modulates MAP kinase activity). Strikingly, many of the signaling genes induced within 4 hr of E~2~ exposure have roles in the regulation of vascular permeability in other tissues, suggesting that they may be involved directly in initiating the influx of fluid into the uterus at this time ([Figure 4B](#f4-ehp0112-001589){ref-type="fig"}). These genes include angiogenic/vascular cell growth factors (*VEGF, PLGF, ADM, ANGPT2, TGFB2*), vasoactive serine proteases (*KLK2, KLK6, KLK9, KLK22*), and vascular endothelial receptors (*IL17R, BDKRB1, ENG, GNA13*). Furthermore, the vascular growth factor receptors *TIE1* and *TIE2* are rapidly down-regulated in response to E~2~ ([Figure 4B](#f4-ehp0112-001589){ref-type="fig"}), which may serve to attenuate the uptake of fluid after 4 hr. Collectively, these genes shed light on the mechanism by which E~2~ promotes fluid uptake in the uterus and provide a clear link between gene expression changes and histologic changes occurring at this time.

Transcriptional Regulators
--------------------------

The sequence-specific transcription factors induced during the first 4 hr of the response can be divided into four main classes ([Figure 4C](#f4-ehp0112-001589){ref-type="fig"}). The first contains members of the Jun, Fos, and ATF subgroups of transcription factors (*C-FOS, FOSB, C-JUN, JUNB, ATF3, ATF4, ATF5*) that form AP-1 dimers implicated in the regulation of cell proliferation and survival ([@b48-ehp0112-001589]). The second class contains genes that control cell differentiation during the development of a number of tissues (*SOX11, SOX18, HEY1, CART1, PRX2, SMAD7, ID1*). The early induction of members of this class suggests that E~2~ deploys a diverse range of gene expression networks to control cell growth and differentiation in the uterus. The third class contains two genes that encode co-regulators for nuclear receptors (*RIP140*, *NCOR2*), suggesting that these may act to modulate ER-mediated responses to E~2~ in the uterus. The fourth class of genes encodes presumed transcriptional regulators of unknown function (e.g., *GIF*).

We conclude that the initial response to E~2~ serves to *a*) modulate the activities of intra- and intercellular signaling pathways that, among other functions, promote vascular permeability and fluid uptake and *b*) up-regulate the expression levels of transcription factors that promote growth and differentiation. These early gene expression changes facilitate the amplification of the originating hormonal signal and set into motion the series of events that result in uterine growth and differentiation.

Phase 2: Coordinated Induction of Genes Required for mRNA and Protein Synthesis
-------------------------------------------------------------------------------

No increase in uterine weight or obvious changes in uterine histology occur between 4 and 8 hr ([Figures 1](#f1-ehp0112-001589){ref-type="fig"} and [2](#f2-ehp0112-001589){ref-type="fig"}). Nevertheless, our data reveal that this phase is associated with the induction of a large cluster of genes ([Figure 5](#f5-ehp0112-001589){ref-type="fig"}). Most are induced 2 hr after E~2~ administration, reach maximal expression at 4 or 8 hr, and return to control or subcontrol levels by 48 hr ([Figure 5B](#f5-ehp0112-001589){ref-type="fig"}). Most of these genes play roles in mRNA and protein synthesis, demonstrating that the bulk of transcriptional activity occurring at this time functions to increase the capacity of the uterus for new protein synthesis. This is consistent with earlier observations that exposure to E~2~ results in a rapid increase in the mRNA and protein content of the uterus ([@b6-ehp0112-001589]). Our data define the molecular basis for these prior observations and identify the genes targeted by ERs to induce these effects.

In a broad sense, protein synthesis includes the interlinked processes of transcription, mRNA processing, mRNA export into the cytoplasm, protein translation, and protein folding ([@b38-ehp0112-001589], and references therein; [Figure 5G](#f5-ehp0112-001589){ref-type="fig"}). Our data reveal the coordinated induction of genes involved in each of these processes ([Figure 5A](#f5-ehp0112-001589){ref-type="fig"}--F). These genes include *a*) components of the RNAP II general transcription machinery (*RPB8*, *RPB10, TAF10*; [Figure 5A](#f5-ehp0112-001589){ref-type="fig"}); *b*) transcription termination and polyadenylation factors (*NSAP1*; [Figure 5A](#f5-ehp0112-001589){ref-type="fig"}); *c*) mRNA splicing factors (*SFPQ, U2AF1, RNPS1*; [Figure 5A](#f5-ehp0112-001589){ref-type="fig"}); *d*) mRNA export proteins (*NXF1*; [Figure 5C](#f5-ehp0112-001589){ref-type="fig"}); *e*) protein translation factors (*EIF1A, EIF2A, EIF2B, EIF3*; ribosomal proteins *RPL11, RPL12, RPL20, RPL52*, *RPS18b*, and tRNA synthetases *VALRS*, *GLURS, PHERS*; [Figure 5D](#f5-ehp0112-001589){ref-type="fig"}), and *f* ) protein folding factors (*FKBP4*, *CCT3, CCT6a, CCT7, CCT8*; [Figure 5E](#f5-ehp0112-001589){ref-type="fig"}). The down-regulation of several genes associated with transcriptional repression (*HDA1, TGIF, MAD4, EZH1*) and mRNA degradation (*AUH*; [Figure 5B](#f5-ehp0112-001589){ref-type="fig"}) may also contribute to the general elevation of mRNA synthesis. We also note a concurrent increase in the expression of components of the ubiquitin--proteasome proteolytic pathway (*PAD1, SUG1*; [Figure 5F](#f5-ehp0112-001589){ref-type="fig"}) and genes whose products are required for the nuclear import and export of proteins (*IMPORTIN*α*2, IMPORTIN*α*3*, *RAE1, G3BP2*; [Figure 5C](#f5-ehp0112-001589){ref-type="fig"}), indicating that E~2~ additionally elevates proteasome levels and nuclear-cytoplasmic protein transport activity at this time. We conclude that E~2~ is able to increase protein synthesis activity in the uterus by altering the expression of genes involved in all aspects of the protein biosynthesis pathway.

Therefore, during the first two phases of the transcriptional program, E~2~ induces the expression of a battery of sequence-specific transcriptional regulators (phase 1; [Figure 4C](#f4-ehp0112-001589){ref-type="fig"}) and then induces the expression of genes in the protein synthesis pathway (phase 2; [Figure 5](#f5-ehp0112-001589){ref-type="fig"}). It appears, therefore, that, during phase 1, E~2~ specifies the gene expression networks that will be active, and then ensures during phase 2 that these networks have sufficient mRNA and protein synthesis capacity to operate. In addition the increased expression of components of the RNA and protein synthesis machinery is likely to be a prerequisite for proliferation in the uterus because cells must increase their mass before division to provide sufficient cellular components required for survival of the daughter cells ([@b34-ehp0112-001589]). Consistent with this, we note that induction of protein synthesis components immediately precedes the up-regulation of genes required for proliferation ([Figure 6](#f6-ehp0112-001589){ref-type="fig"}; see below). An additional function of the increased uterine capacity for protein synthesis may be to facilitate the production of the abundant cytoarchitectural and secreted proteins induced at the end of the uterotrophic response (see below).

Phase 3: Coordinated Regulation of Genes Controlling Chromosome Replication and the Cell Cycle
----------------------------------------------------------------------------------------------

The next phase in the uterotrophic response occurs between 8 and 24 hr and involves an approximate doubling in uterine weight ([Figure 1A](#f1-ehp0112-001589){ref-type="fig"}) and a large increase in the thickness of the luminal epithelium ([Figures 2C](#f2-ehp0112-001589){ref-type="fig"}, [6A](#f6-ehp0112-001589){ref-type="fig"}). A quantitative histologic analysis of mitotic figures in the uterine cells ("Materials and Methods") revealed a clear and statistically significant (*p* \< 0.01) increase with E ~2~ at 24 hr, whereas no E~2~-dependent increase was observed at 8, 48, or 72 hr ([Table 1](#t1-ehp0112-001589){ref-type="table"}, [Figure 6A](#f6-ehp0112-001589){ref-type="fig"}). These observations are consistent with previous studies showing that most cells in the immature rodent uterus are stimulated to leave their quiescent state and divide synchronously under the influence of E~2~ ([@b19-ehp0112-001589]; [@b45-ehp0112-001589]).

We found that genes required for the replication of chromosomal DNA (*PCNA*, *FEN1, CDC6, MCM2, MCM3, MCM4, MCM5, ORC1, ORC6, RRM1, RRM2*) and genes required for postreplicative phases of the cell division cycle (e.g., *CCNB1, PLK1*) are coordinately induced and reach maximal expression levels between 8 and 24 hr ([Figure 6B](#f6-ehp0112-001589){ref-type="fig"}), consistent with the timing of the histologic changes observed in [Figure 6A](#f6-ehp0112-001589){ref-type="fig"}. Genes required for maintaining genome integrity (*CHK1, CKS1, GEMININ*) and the epigenetic status of newly replicated DNA (*CAF-1 p60, AHCY*) are also up-regulated at 8 and/or 24 hr ([Figure 6B](#f6-ehp0112-001589){ref-type="fig"}). It is striking that after their induction during the proliferative phase (8--24 hr), the expression levels of most genes that regulate chromosome replication and cell division are reduced to levels well below those of control animals ([Figure 6B](#f6-ehp0112-001589){ref-type="fig"}). This suggests that mechanisms exist for the active repression of these genes to prevent further rounds of proliferation. Declining E~2~ levels in mice 48 hr after a single subcutaneous injection may also contribute to the cessation of proliferation. Together, these data provide a molecular explanation for the changes in uterine weight and histology that occur between 8 and 24 hr ([Figures 1A](#f1-ehp0112-001589){ref-type="fig"}, [2](#f2-ehp0112-001589){ref-type="fig"}, and [6A](#f6-ehp0112-001589){ref-type="fig"}) and support the assertion that the early increase in weight seen at 4 hr is due to fluid uptake. Furthermore, these gene expression changes demonstrate that cell proliferation is restricted to a narrow window of time between 8 and 24 hr by the coordinated regulation of chromosome replication and cell division genes.

Regulation of Cell Division
---------------------------

Our data also provide insight into the mechanisms by which E~2~ releases cells of the immature uterus from quiescence and promotes cell division. The E~2~-induced expression profile of *E2F1*, a key transcriptional regulator of DNA replication genes ([@b36-ehp0112-001589]), closely parallels the induction of the chromosome replication genes ([Figure 6B](#f6-ehp0112-001589){ref-type="fig"}), consistent with the proposal that *E2F1* regulates the expression of components of the DNA replication fork in human breast cancer cell lines exposed to E~2~ ([@b24-ehp0112-001589]). Our data indicate that release from quiescence also involves the E~2~-induced down-regulation of genes that maintain cells in a growth-arrested state (*KIP1*, *CCNG2, CCNG1*). The principle way in which mitogens induce proliferation of quiescent cells involves a reduction in levels of the Kip1 protein, which inhibits the activities of cyclin--cdk complexes and induces cell cycle arrest ([@b37-ehp0112-001589]). We found that *KIP1* was down-regulated within 1 hr of E~2~ exposure and remains repressed over a period of at least 24 hr, only reaching control levels when cell proliferation has ceased ([Figure 6C](#f6-ehp0112-001589){ref-type="fig"}). Furthermore, E~2~ may promote degradation of the Kip1 protein via the induction of *CDC34* ([Figure 6C](#f6-ehp0112-001589){ref-type="fig"}), a gene that has been implicated in the ubiquitin-mediated degradation of Kip1 ([@b20-ehp0112-001589]). These data suggest that E~2~ promotes cell proliferation by coordinately reducing Kip1 mRNA and protein levels. It is not clear whether *KIP1* is a direct or indirect target of the activated ERs. However, *KIP1* gene expression is controlled by ras-mediated PI3K signaling pathways ([@b37-ehp0112-001589]), components of which are up-regulated rapidly in response to E~2~ (e.g., *DEXRAS1*, *RASSF1*; [Figure 4B](#f4-ehp0112-001589){ref-type="fig"}).

Suppression of Apoptosis
------------------------

E~2~ protects against apoptosis in a number of tissues, including brain, testes, and uterus ([@b53-ehp0112-001589]). Although the anti-apoptotic activity of estrogen in the uterus is thought to play a crucial role in the maintenance of uterine homeostasis, the mechanistic basis for this action has not been defined. Our data reveal that E~2~ induces the expression of anti-apoptotic genes (*BAG2, BAG3, DAD1*) while simultaneously down-regulating the expression of pro-apoptotic genes (*CASP2*, *NIX*; [Figure 6D](#f6-ehp0112-001589){ref-type="fig"}). Thus, apoptosis appears to be suppressed through transcriptional mechanisms during E~2~-induced uterine growth. Consistent with these observations, E~2~ also induces the apoptotic regulators *BCL2* and *BAG1* in cultured breast cancer cells ([@b43-ehp0112-001589]; [@b50-ehp0112-001589]). It will be important to determine whether estrogens elicit similar changes in the expression of apoptosis-regulating genes in other tissues.

Phase 4: Induction of Genes Involved in Uterine Cell Differentiation and Defense Responses
------------------------------------------------------------------------------------------

The period from 24 to 72 hr after E ~2~ exposure is associated with remodeling of the luminal epithelial cell layer, including the formation of secretory epithelial cells and a glycocalyx layer consisting of glycoproteins ([@b40-ehp0112-001589]; [@b59-ehp0112-001589]). These changes result in the formation of a highly differentiated epithelial layer that is primed for cell recognition and adhesion events necessary for embryo attachment and implantation.

Changes in Cytoarchitecture
---------------------------

The final phase of the uterotrophic response coincides with the induction of a battery of genes involved in the cytoarchitectural remodeling of proliferating uterine cells, thus providing a further link between phenotypic and gene expression changes ([Figure 7A](#f7-ehp0112-001589){ref-type="fig"}). These genes encode components of desmosomes (*DSG2*), gap junctions (*CX26*), tight junctions (*CLDN4, CLDN7*), the cornified envelope (*SPRR1A, 2A, 2B, 2E, 2F, 2G, 2I, 2J*), intermediate filaments (*KRT19*), and a variety of cell-surface and extracellular-matrix glycoproteins (*SPP1, BGP1, BGP2, MUC1, TROP2, CLU*). The latter class of genes is likely to contribute to the formation of the glycocalyx layer present on differentiated uterine epithelium ([@b59-ehp0112-001589]). The concomitant E~2~-dependent induction of a number of enzymes required for carbohydrate metabolism (*MAN2B1, GALNT3*) may provide the increase in sugar metabolism necessary for the production of these glycoproteins. E~2~ also induces genes encoding ion channels that regulate the balance of Na^+^ absorption and Cl^−^ secretion across the endometrial epithelium to maintain a luminal fluid microenvironment suitable for implantation (*CFTR, CLCA3, MAT8*; [Figure 7A](#f7-ehp0112-001589){ref-type="fig"}).

Defense Responses
-----------------

A number of genes involved in host defense processes or detoxification are first regulated between 24 and 72 hr ([Figure 7B](#f7-ehp0112-001589){ref-type="fig"}). We speculate that the products of these genes may provide an environment that is protective of, and facilitates, embryo implantation and development. These include genes encoding lysosomal enzymes (*LYZP, LYZM, CTSH CTSL, CTSS, LGMN*), genes involved in detoxification and clearance of xenobiotics (*GSTO1, GSTT2, UGT1A1*), and genes involved in immune and inflammatory responses (*CD14, MX1, PIGR*). The up-regulation of genes encoding chemoattractant cytokines ([Figure 7C](#f7-ehp0112-001589){ref-type="fig"}) for infiltrating eosinophils (*EOTAXIN*) and monocytes (*MCP1*/*3*) is consistent with previous observations of immune cell infiltration into the uterus ([@b12-ehp0112-001589], and references therein). Another E~2~-regulated defense response may be provided by the induction of LTF ([@b23-ehp0112-001589]), an iron-binding protein with bacteriostatic activity ([@b49-ehp0112-001589]). Our data reveal the induction of two additional iron metabolism genes at this time (*CP, LCN2*; [Figure 7E](#f7-ehp0112-001589){ref-type="fig"}; [@b18-ehp0112-001589]), suggesting a role for iron homeostasis in the uterotrophic response to E~2~.

Several components of the complement system are also induced 48--72 hr after exposure to E ~2~. These include *C1QA, C1QB, C1QC, C2, C3, C4, CFH,* and *CFI* ([Figure 7D](#f7-ehp0112-001589){ref-type="fig"}). Although many complement components have been identified in female reproductive epithelium, only *C3* has previously been established as an E~2~-responsive gene ([@b51-ehp0112-001589]). In addition to participating in immune and inflammatory responses and host resistance, there is increasing evidence that complement functions in tissue remodeling and organ regeneration ([@b26-ehp0112-001589]). Intriguingly, complement also influences mammalian reproduction and particularly the integrity of maternofetal interfaces during pregnancy ([@b4-ehp0112-001589]; [@b26-ehp0112-001589]). Therefore, it is possible that the complement system may play a noninflammatory role in the uterotrophic response.

Evidence for a Transcriptional Cascade in the Uterus
----------------------------------------------------

It is striking that many different induction profiles can be seen in the genes regulated by E~2~: some genes are induced within 1 hr of exposure, whereas others are not induced until 48 hr ([Figure 3B](#f3-ehp0112-001589){ref-type="fig"}). The induction of a large number of sequence-specific transcription factors during the first phase of the response suggests that a transcriptional cascade may operate in the uterus, with the products of genes induced at the beginning of the program regulating the transcription of those toward the end. The regulation of the SPRR genes provides evidence for the existence of such a cascade ([Figure 8](#f8-ehp0112-001589){ref-type="fig"}). The mouse SPRR genes are located in a tandem array at the same chromosomal locus, and their transcription is regulated by the AP-1 and Ets transcription factors ([@b41-ehp0112-001589]; [Figure 8A](#f8-ehp0112-001589){ref-type="fig"}). Eight members of the SPRR gene family are induced between 4 and 72 hr, with maximal induction occurring between 24 and 48 hr ([Figure 8B](#f8-ehp0112-001589){ref-type="fig"}). Intriguingly, the mRNAs encoding Ets2 and components of AP-1 (c-Jun, JunB, c-Fos, FosB, and Atf3, Atf4, Atf5) are maximally induced during the first phase of the uterotrophic response, between 1 and 4 hr ([Figure 8B](#f8-ehp0112-001589){ref-type="fig"}). We speculate, therefore, that a transcriptional cascade operates, in which ER-αor ER-βinduces the expression of Ets2 and AP-1 components, which in turn regulate the transcription of the SPRR genes ([Figure 8C](#f8-ehp0112-001589){ref-type="fig"}). Alternatively, it is possible that ER-αor ER-βcooperates with Ets2 and AP-1 to regulate the expression of the SPRR genes. In this way, transcription of the SPRR genes would not begin until sufficient levels of Ets2 and AP-1 were present. Consistent with this model, feed-forward loops (in which a transcriptional regulator controls a second transcription factor that then functions in concert with the initial regulator on a common downstream target gene) are emerging as common mechanisms in eukaryotes for transcriptional networks ([@b21-ehp0112-001589]). It is likely that analysis of the regulatory regions of other E~2~-responsive genes during the uterotrophic response will suggest the existence of additional transcriptional networks.

Discussion
==========

Our data describe at an unprecedented level of detail the molecular events that initiate and drive uterine physiologic changes upon exposure to the sex steroid hormone E ~2~ in the immature mouse uterus. Gene expression profiling reveals that E~2~ induces a multistage and tightly coordinated transcriptional program that regulates successive and functionally interlinked cellular processes during the uterotrophic response ([Figure 9](#f9-ehp0112-001589){ref-type="fig"}). The temporal patterns of gene expression we have identified for E~2~ are consistent with, and extend, those reported recently for the uterotrophic response of immature, ovariectomized mice after exposure to 17α-ethynylestradiol ([@b10-ehp0112-001589]), in which concordant temporal responses were seen for genes involved in several functional categories in [Figure 9](#f9-ehp0112-001589){ref-type="fig"}. These include RNA and protein metabolism, cell cycle regulation, immune responses, and complement components. Furthermore, many of the genes regulated by exogenous E~2~ in our study are also differentially regulated in response to endogenous hormones ([@b52-ehp0112-001589]).

Comparison of gene expression changes with alterations in uterine weight and histologic alterations, and analysis of gene expression data according to gene function allowed us to implicate specific groups of genes in driving water imbibition in the stromal endothelium, synchronous cell proliferation, and cytoarchitectural changes associated with luminal epithelial cell differentiation. These data thus provide a detailed mechanistic view of the relationships between the uterotrophic response and the underlying transcriptional program. Furthermore, this work demonstrates that comparison of temporal changes in gene expression and conventional toxicology parameters (uterine weight and histologic changes) can provide an understanding of the relationships between gene expression patterns and phenotypic change.

E~2~ can regulate transcription through a combination of at least two distinct signaling pathways: *a*) via activation of the nuclear transcription factors ER-αand ER-β([@b13-ehp0112-001589]; [@b27-ehp0112-001589]; [@b31-ehp0112-001589]; [@b54-ehp0112-001589]) and *b*) via extranuclear or "nongenomic" signaling events ([@b9-ehp0112-001589]; [@b15-ehp0112-001589]; [@b30-ehp0112-001589]). The transcriptional responses to E~2~ that we have defined here are likely to involve a combination of direct gene regulation by nuclear ERs and indirect gene regulation via extranuclear signaling pathways. Although the uterus of the immature mouse expresses both ER subtypes (αand β) at comparable levels ([@b57-ehp0112-001589]), recent transcript profiling studies using ovariectomized ER-knockout mice revealed a predominant role for ER-αin the regulation of estrogen-responsive genes in the uterus ([@b17-ehp0112-001589]; [@b55-ehp0112-001589]) consistent with the observation that only a partial uterotrophic response occurs in ER-αknockout mice ([@b25-ehp0112-001589]). Therefore, it is likely that most E~2~-responsive genes we have identified are regulated by ER-α. However, identification of the direct gene targets for each ER subtype will ultimately require the development of methods for measuring the occupancy of receptor subtypes at promoters *in vivo*. Nevertheless, our temporal analysis of E~2~-responsive genes provides novel insights into the transcriptional cascades that are initiated through E~2~-responsive transcription factors.

The molecular events described here for the reference natural estrogen E~2~ provide the basis for understanding how other estrogenic chemicals, including synthetic estrogens and phytoestrogens, induce their effects ([@b29-ehp0112-001589]). Increasing attention is being paid to the use of gene expression changes in the uterus for the identification of surrogate markers for short-term rodent estrogenicity assays ([@b32-ehp0112-001589], [@b33-ehp0112-001589]; [@b39-ehp0112-001589]; [@b56-ehp0112-001589]), and our data reveal a large number of novel candidate marker genes. The insights provided by these data, into how an ER ligand coordinates transcriptional regulatory networks that result in proliferation and differentiation in a complex organ, provide a paradigm for understanding the modes of action of other nuclear receptors.

Supplementary Material
======================

![Uterotrophic response to a single dose of E~2~. (*A*) Uterine blotted weight. Data for replicate studies A and B are mean ± SD from 10 immature female mice in each treatment group. Five animals per group were used in replicate study C. (*B*) Temporal expression profile of the estrogen-responsive genes complement component C3 and C-FOS. Quantitative RT-PCR analysis of *FOS* and *LTF* gene expression from three independent time-course studies (*A--C*) and comparison with microarray data. Each RT-PCR data point represents a fold value, obtained using the comparative *C~t~* (threshold cycle) method, for E~2~-induced change in gene expression relative to time-matched vehicle controls. The fold induction value is relative to the endogenous control gene *RPB1* and to treatment, that is, estrogen/untreated. Microarray data are ratios (E~2~:time-matched vehicle control) of normalized Affymetrix GeneChip signal intensities (see [Figure 3A](#f3-ehp0112-001589){ref-type="fig"} and "Materials and Methods").\
\**p* \< 0.05;\
\*\**p* \< 0.01.](ehp0112-001589f1){#f1-ehp0112-001589}

![Histologic analysis of uterotrophic response to a single dose of E~2~. (*A)* Panels show longitudinal 0.3-μm--thick paraffin sections of uteri stained with hematoxylin and eosin; bar = 50 μm. Luminal space (L), luminal epithelium (LE), stromal endothelium (SE), and glandular epithelium (GE) are indicated. (*B*) Height of stromal endothelial cell layer. (*C*) Height of luminal epithelial cell layer. Data in *B* and *C* are mean ± SD from 10 immature female mice in each treatment group. Solid bars, E~2~; open bars, AO.\
\**p* \< 0.05;\
\*\**p* \< 0.01.](ehp0112-001589f2){#f2-ehp0112-001589}

![(*A*) Experimental strategy for phenotypic anchoring of E~2~-responsive genes during uterotrophic response. Three independent biologic replicate studies were performed in which we analyzed seven different time points for E~2~-treated animals and the equivalent time points for vehicle-treated animals. (*B*) Staged transcriptional response of the immature mouse uterus to E~2~. Gene tree generated by hierarchical clustering of 3,538 E~2~-responsive genes showing clusters (labeled A--I) of temporally co-regulated genes. The genes clustered in groups A--I are further annotated using gene ontology analyses in [Figures 4](#f4-ehp0112-001589){ref-type="fig"}--[7](#f7-ehp0112-001589){ref-type="fig"}. The color scale indicates the mean fold change of E~2~-induced gene expression relative to time-matched AO-treated control samples (based on the three independent studies shown in [Figure 1A](#f1-ehp0112-001589){ref-type="fig"}).](ehp0112-001589f3){#f3-ehp0112-001589}

![Phase 1: rapid induction of transcriptional regulators and signaling components by E~2~. (*A*) Water imbibition and increased vascular activity in stromal endothelium (SE) 2 and 4 hr after a single dose of E~2~. Longitudinal 0.3-μm--thick paraffin sections of uteri stained with hematoxylin and eosin are shown. Scale bar, 50 μm. (*B*) Coordinate expression of genes encoding signaling components. Genes marked with a red circle have functions associated with altered vascular permeability and may drive the water imbibition seen at this time. (*C*) Coordinate expression of genes encoding transcription factors. Detailed quantitative data for genes encoding AP-1 transcription factors are shown in [Figure 8B](#f8-ehp0112-001589){ref-type="fig"}. Gene trees were generated by supervised hierarchical clustering; genes with related functions were selected from clusters of temporally co-regulated E~2~-responsive genes ([Figure 3B](#f3-ehp0112-001589){ref-type="fig"}) using universal gene ontology descriptions. The color scale for fold change in expression is identical to that used in [Figure 3B](#f3-ehp0112-001589){ref-type="fig"}. Data derived from independent Affymetrix probe sets are shown for *GIF* and *SOX18*. See [Appendix](#ta1-ehp0112-001589){ref-type="table"} for gene nomenclature and Affymetrix probe sets.](ehp0112-001589f4){#f4-ehp0112-001589}

![Phase 2: coordinated induction of genes required for mRNA and protein synthesis. Coordinated expression of genes involved in (*A*) RNA synthesis, (*B*) transcriptional repression, (*C*) nuclear import/export, (*D*) protein translation, (*E*) protein folding, and (*F*) protein degradation. Gene trees were generated as described in [Figure 4](#f4-ehp0112-001589){ref-type="fig"}. Data derived from independent Affymetrix probe sets are shown for *eIF1A*, *eRF1*, and *CCT3*. See [Appendix](#ta1-ehp0112-001589){ref-type="table"} for gene nomenclature and Affymetrix probe sets. (*G*) Schematic overview of RNA and protein synthesis in eukaryotes, showing machinery involved in each step of the process. Reprinted from [@b38-ehp0112-001589], with permission from Elsevier.](ehp0112-001589f5){#f5-ehp0112-001589}

![Phase 3: coordinated regulation of genes controlling chromosome replication and the cell cycle. (*A*) Thickening of luminal (LE) and glandular epithelium (GE) and increased number of mitotic cells (indicated by arrowheads) between 8 and 24 hr after a single dose of E~2~. Longitudinal 0.3-μm--thick paraffin sections of uteri were stained with hematoxylin and eosin. Scale bar, 50 μm. Coordinated expression of genes involved in (*B*) chromosome replication and cell division, (*C*) cell-cycle regulation, (*D*) and apoptosis. Gene trees were generated as described in [Figure 4](#f4-ehp0112-001589){ref-type="fig"}. Data derived from independent Affymetrix probe sets are shown for *MCM3*. See [Appendix](#ta1-ehp0112-001589){ref-type="table"} for gene nomenclature and Affymetrix probe sets.](ehp0112-001589f6){#f6-ehp0112-001589}

![Phase 4: induction of genes involved in uterine cell differentiation and defense responses. (*A*) Cytoarchitecture; (*B*) defense responses; (*C*) chemoattractant cytokines; (*D*) complement; and (*E*) iron homeostasis. Gene trees were generated as described in [Figure 4](#f4-ehp0112-001589){ref-type="fig"}. Data derived from independent Affymetrix probe sets are shown for *SPRR2A*, *CD133*, *TROP2*, *BGP1*, *CLU*, *KRT19*, and *CFH*. Detailed quantitative data for the SPRR gene family are shown in [Figure 8B](#f8-ehp0112-001589){ref-type="fig"}. See [Appendix](#ta1-ehp0112-001589){ref-type="table"} for gene nomenclature and Affymetrix probe sets.](ehp0112-001589f7){#f7-ehp0112-001589}

![Evidence for a transcriptional regulatory network during the uterotrophic response. (*A*) Organization of mouse SPRR genomic locus that is coordinately regulated by the transcription factors AP-1 and Ets. (*B*) E~2~-induced expression (mean + SD) of genes encoding AP-1 and Ets transcription factors temporally precedes the coordinate regulation of the tandem array of SPRR genes. (*C*) Feed-forward model for an ER-dependent transcriptional cascade in the uterus. Transcriptional regulators are represented by blue circles. Gene promoters are represented by white rectangles. See [Appendix](#ta1-ehp0112-001589){ref-type="table"} for gene nomenclature and Affymetrix probe sets.](ehp0112-001589f8){#f8-ehp0112-001589}

![Summary of the transcriptional program associated with E~2~-induced uterine growth showing the successive regulation of genes with distinct molecular functions.](ehp0112-001589f9){#f9-ehp0112-001589}

###### 

Quantitative histologic analysis of mitotic figures in uterine cells after exposure to E~2~ for 8, 24, 48, and 72 hr.[*^a^*](#tfn2-ehp0112-001589){ref-type="table-fn"}

       Mitosis/mm^2^ (mean ± SD)   
  ---- --------------------------- ---------------------------------------------------------------
  8    1.36 ± 1.81                 0.51 ± 0.41
  24   3.86 ± 5.05                 25.15 ± 6.37[\*\*](#tfn3-ehp0112-001589){ref-type="table-fn"}
  48   3.81 ± 0.83                 3.46 ± 3.26
  72   3.88 ± 2.28                 1.67 ± 1.77

Quantitative mitotic index data were derived from four animals per group.

Data were assessed for statistical significance using ANOVA and a two-sided Student *t*-test (see "Materials and Methods").

*p* \< 0.01.

###### 

**Appendix.** Gene nomenclature and Affymetrix probe sets for [Figures 4](#f4-ehp0112-001589){ref-type="fig"}--[8](#f8-ehp0112-001589){ref-type="fig"}.[*^a^*](#tfn4-ehp0112-001589){ref-type="table-fn"}

  Gene symbol                                                                               Affymetrix Probe Set   Gene description
  ----------------------------------------------------------------------------------------- ---------------------- ------------------------------------------------------------------------------------------------
  **[Figure 4B](#f4-ehp0112-001589){ref-type="fig"} ---Signaling components**                                      
  IL17R                                                                                     99992_at               interleukin 17 receptor
  RAP1                                                                                      160822_at              Rap1, GTPase-activating protein 1
  DEXRAS1                                                                                   99032_at               RAS, dexamethasone-induced 1
  MKP1                                                                                      104598_at              dual specificity phosphatase 1
  WNT4                                                                                      103238_at              wingless-related MMTV integration site 4
  IGFBP10                                                                                   92777_at               cysteine rich protein 61
  PIP92                                                                                     99109_at               immediate early response 2
  PIM3                                                                                      96841_at               similar to serine/threonine-protein kinase pim-3
  ARHU                                                                                      96747_at               ras homolog gene family, member U
  CISH3                                                                                     162206_f\_at           cytokine inducible SH2-containing protein 3
  NAB2                                                                                      100962_at              Ngfi-A binding protein 2
  SOCS3                                                                                     92232_at               cytokine inducible SH2-containing protein 3
  EPLG2                                                                                     98407_at               ligand for receptor tyrosine kinase ELK
  IL17R                                                                                     99991_at               interleukin 17 receptor
  CDKN1A                                                                                    98067_at               cyclin-dependent kinase inhibitor 1A (P21)
  CDKN1A                                                                                    94881_at               cyclin-dependent kinase inhibitor 1A (P21)
  WSB1                                                                                      98946_at               WD-40-repeat-containing protein with a SOCS box
  VEGF                                                                                      103520_at              vascular endothelial growth factor A
  GADD45                                                                                    102292_at              growth arrest and DNA-damage-inducible 45
  SYT                                                                                       99610_at               synovial sarcoma translocation, chromosome 18
  SOCS1                                                                                     92832_at               cytokine inducible SH2-containing protein 1
  GADD45g                                                                                   101979_at              growth arrest and DNA-damage-inducible 45 gamma
  GLY96                                                                                     94384_at               immediate early response 3
  MAPKAP2                                                                                   160353_i\_at           MAP kinase-activated protein kinase 2
  KLK22                                                                                     101289_f\_at           epidermal growth factor binding protein type 1
  TROB                                                                                      99532_at               tob family
  RGS3                                                                                      160747_at              regulator of G-protein signaling 3
  GNA13                                                                                     100514_at              guanine nucleotide binding protein, alpha 13
  RAB11A                                                                                    96238_at               RAB11a, member RAS oncogene family
  PLGF                                                                                      92909_at               placental growth factor
  BDKRB1                                                                                    101748_at              bradykinin B1 subtype receptor
  CF3                                                                                       97689_at               coagulation factor III
  PDK4                                                                                      102049_at              pyruvate dehydrogenase kinase, isoenzyme 4
  HERPUD1                                                                                   95057_at               homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
  MYD116                                                                                    160463_at              myeloid differentiation primary response gene 116
  NORE1                                                                                     102028_at              Ras association (RalGDS/AF-6) domain family 5
  NET1A                                                                                     94223_at               neuroepithelial cell transforming gene 1
  GEM                                                                                       92534_at               GTP binding protein (gene overexpressed in skeletal muscle)
  SNRK                                                                                      97429_at               SNF related kinase
  ALASH                                                                                     93500_at               aminolevulinic acid synthase 1
  NTTP1                                                                                     161171_at              dual specificity phosphatase 8
  MAPKAP2                                                                                   95721_at               MAP kinase-activated protein kinase 2
  MEK1                                                                                      92585_at               mitogen activated protein kinase kinase 1
  RGSr                                                                                      94378_at               regulator of G-protein signaling 16
  RASSF1                                                                                    102379_at              Ras association (RalGDS/AF-6) domain family 1
  NGEF                                                                                      93178_at               neuronal guanine nucleotide exchange factor
  C-KIT                                                                                     99956_at               kit oncogene
  NOTCH1                                                                                    97497_at               Notch gene homolog 1
  BTG3                                                                                      96146_at               B-cell translocation gene 3
  PC4                                                                                       160092_at              interferon-related developmental regulator 1
  SGK                                                                                       97890_at               serum/glucocorticoid regulated kinase
  ADM                                                                                       102798_at              adrenomedullin
  ANGPT2                                                                                    92210_at               angiopoietin 2
  UBQLN1                                                                                    95601_at               ubiquilin 1
  THBS1                                                                                     160469_at              thrombospondin
  ROCK2                                                                                     98504_at               rho-associated coiled-coil forming kinase 2
  SNK                                                                                       92310_at               serum-inducible kinase
  MAP2K3                                                                                    93315_at               mitogen activated protein kinase kinase 3
  ENG                                                                                       100134_at              endoglin
  PTDSR                                                                                     95486_at               phosphatidylserine receptor
  SWIP2                                                                                     160296_at              WD-40-repeat-containing protein with a SOCS box
  AKT                                                                                       100970_at              thymoma viral proto-oncogene 1
  RHOC                                                                                      96056_at               ras homolog gene family, member C
  TGFB2                                                                                     93300_at               transforming growth factor, beta 2
  EPCR                                                                                      98018_at               protein C receptor, endothelial
  KLK6                                                                                      100061_f\_at           kallikrein 6
  GALN                                                                                      100407_at              galanin
  NEDD4B                                                                                    103907_at              neural precursor cell expressed, developmentally down-regulated gene 4-like
  KLK22                                                                                     95775_f\_at            kallikrein 22
  KLK9                                                                                      94716_f\_at            kallikrein 9
  MCP1                                                                                      102736_at              platelet-derived growth factor-inducible protein JE
  TIE1                                                                                      99936_at               tyrosine kinase receptor 1
  RAMP1                                                                                     104680_at              receptor (calcitonin) activity modifying protein 1
  PGF                                                                                       97769_at               prostaglandin F receptor
  PDGFαRA                                                                                   95079_at               platelet derived growth factor receptor, alpha polypeptide
  OB-RGRP                                                                                   93600_at               leptin receptor
  ERK1                                                                                      101834_at              mitogen activated protein kinase 3
  GRB7                                                                                      103095_at              growth factor receptor bound protein 7
  ADCY6                                                                                     102321_at              adenylate cyclase 6
  TIE1                                                                                      161184_f\_at           tyrosine kinase receptor 1
  GNAI1                                                                                     104412_at              guanine nucleotide binding protein, alpha inhibiting 1
  ADCY7                                                                                     103392_at              adenylate cyclase 7
  TIE2                                                                                      102720_at              endothelial-specific receptor tyrosine kinase
  GPCR26                                                                                    100435_at              endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2
  **[Figure 4C](#f4-ehp0112-001589){ref-type="fig"}---Transcription factors**                                      
  GIF                                                                                       99603_g\_at            TGFB inducible early growth response
  GIF                                                                                       99602_at               TGFB inducible early growth response
  ETS2                                                                                      94246_at               E26 avian leukemia oncogene 2, 3' domain
  ID1                                                                                       100050_at              inhibitor of DNA binding 1
  SMAD7                                                                                     92216_at               MAD homolog 7
  C-JUN                                                                                     100130_at              Jun oncogene
  BRF2                                                                                      160273_at              zinc finger protein 36, C3H type-like 2
  IRF8                                                                                      98002_at               interferon concensus sequence binding protein
  AGP/EBP                                                                                   92925_at               CCAAT/enhancer binding protein (C/EBP), beta
  C-FOS                                                                                     160901_at              c-fos oncogene
  KROX24                                                                                    98579_at               zinc finger protein Krox-24
  FOSB                                                                                      103990_at              FBJ osteosarcoma oncogene B
  NR4A1                                                                                     102371_at              N10 nuclear hormonal binding receptor
  SOX18                                                                                     161025_f\_at           SRY-box containing gene 18
  SOX18                                                                                     104408_s\_at           SRY-box containing gene 18
  KROX20                                                                                    102661_at              Early growth response 2
  ESG                                                                                       104623_at              transducin-like enhancer of split 3, homolog of Drosophila E(spl)
  FOG                                                                                       97974_at               zinc finger protein, multitype 1
  NCOR2                                                                                     95129_at               nuclear receptor co-repressor 2
  SOX11                                                                                     101631_at              SRY-box containing gene 11
  C/EBP                                                                                     94466_f\_at            CCAAT/enhancer binding protein alpha (C/EBP), related sequence 1
  PRX2                                                                                      103327_at              paired related homeobox 2
  ATF4                                                                                      100599_at              activating transcription factor 4
  STAT5B                                                                                    100422_i\_at           signal transducer and activation of transcription 5A
  HEY1                                                                                      95671_at               hairy/enhancer-of-split related with YRPW motif 1
  ATF5                                                                                      103006_at              activating transcription factor 5
  C/EBP                                                                                     98447_at               CCAAT/enhancer binding protein
  RIP140                                                                                    103288_at              nuclear receptor interacting protein 1
  CRTR1                                                                                     103761_at              Tcfcp2-related transcriptional repressor 1
  MEF2A                                                                                     93852_at               myocyte enhancer factor 2A
  TIS11                                                                                     92830_s\_at            zinc finger protein 36
  STAT5B                                                                                    100423_f\_at           signal transducer and activation of transcription 5A
  ATF3                                                                                      104155_f\_at           activating transcription factor 3
  CART1                                                                                     100005_at              TNF receptor associated factor 4
  JUNB                                                                                      102362_i\_at           transcription factor junB
  **[Figure 5A](#f5-ehp0112-001589){ref-type="fig"}---RNA synthesis**                                              
  SFPQ                                                                                      99621_s\_at            splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)
  U2AF1                                                                                     97486_at               U2 small nuclear ribonucleoprotein auxiliary factor (U2AF), 35 kDa
  RBMXP1                                                                                    160192_at              RNA binding motif protein, X chromosome retrogene
  DDX21                                                                                     94361_at               DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 21 (RNA helicase II/Gu)
  DDX3                                                                                      101542_f\_at           DEAD (aspartate-glutamate-alanine-aspartate) box polypeptide 3
  NSAP1                                                                                     94985_at               NS1-associated protein 1
  MKI67 bp                                                                                  93342_at               Mki67 (FHA domain) interacting nucleolar phosphoprotein
  ELAVL1                                                                                    94001_at               ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)
  PSP1                                                                                      103393_at              paraspeckle protein 1
  SRP20                                                                                     101003_at              splicing factor, arginine/serine-rich 3 (SRp20)
  JKTBP                                                                                     96084_at               heterogeneous nuclear ribonucleoprotein D-like
  RPA2                                                                                      92225_f\_at            RNA polymerase 1--2 (128 kDa subunit)
  RALY                                                                                      98511_at               hnRNP-associated with lethal yellow
  SFRS10                                                                                    95791_s\_at            splicing factor, arginine/serine-rich 10
  FBL                                                                                       160503_at              fibrillarin
  SNRPA1                                                                                    101506_at              small nuclear ribonucleoprotein polypeptide A'
  TASR                                                                                      98048_at               neural-salient serine/arginine-rich
  RPB10                                                                                     93551_at               RNA polymerase II subunit 10
  AUF1                                                                                      94303_at               heterogeneous nuclear ribonucleoprotein D
  HRMT1L2                                                                                   96696_at               heterogeneous nuclear ribonucleoproteins methyltransferase-like 2
  CGI-110                                                                                   95714_at               pre-mRNA branch site protein p14
  SMN                                                                                       103620_s\_at           survival motor neuron
  RPB8                                                                                      97254_at               RNA binding motif protein
  RNPS1                                                                                     93518_at               ribonucleic acid binding protein S1
  NCL                                                                                       160521_at              nucleolin
  RPA1                                                                                      93620_at               RNA polymerase 1--4 (194 kDa subunit)
  HNRPA2B1                                                                                  93118_at               heterogeneous nuclear ribonucleoprotein A2/B1
  SNRPD1                                                                                    100577_at              small nuclear ribonucleoprotein D1
  H/ALAsnRNP                                                                                97824_at               nucleolar protein family A, member 2
  TAF10                                                                                     103910_at              TAFII30
  DDX24                                                                                     99096_at               DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 13 (RNA helicase A)
  **[Figure 5B](#f5-ehp0112-001589){ref-type="fig"}**                                                              
  MAD4                                                                                      99024_at               Max dimerization protein 4
  EZH1                                                                                      100486_at              enhancer of zeste homolog 1 (Drosophila)
  HDA1                                                                                      104376_at              histone deacetylase 5
  AUH                                                                                       96650_at               AU RNA binding protein/enoyl-coenzyme A hydratase
  TGIF                                                                                      101502_at              TG interacting factor
  **[Figure 5C](#f5-ehp0112-001589){ref-type="fig"}---Nuclear import/export**                                      
  POM121                                                                                    96174_at               nuclear pore membrane protein 121
  NXF1                                                                                      101079_at              nuclear RNA export factor 1 homolog (*S. cerevisiae*)
  IMPORTINa3                                                                                96010_at               karyopherin (importin) alpha 3
  RAE1                                                                                      160466_at              RNA export 1 homolog (S. pombe)
  IMPORTINa2                                                                                92790_at               karyopherin (importin) alpha 2
  G3BP2                                                                                     94913_at               Ras-GTPase-activating protein (GAP120) SH3-domain binding protein 2
  **[Figure 5D](#f5-ehp0112-001589){ref-type="fig"}---Protein translation**                                        
  eIF3S7                                                                                    99101_at               eukaryotic translation initiation factor 3, subunit 7 (zeta, 66/67kDa)
  eIF2B                                                                                     160365_at              eukaryotic translation initiation factor 2, subunit 2 (beta, 38kDa)
  eIF3S4                                                                                    96883_at               eukaryotic translation initiation factor 3, subunit 4 (delta, 44kDa)
  EBNA1-bp2                                                                                 96297_at               EBNA1 binding protein 2
  GLNRS                                                                                     96628_at               glutamyl-prolyl-tRNA synthetase
  NAT1                                                                                      100535_at              eukaryotic translation initiation factor 4, gamma 2
  eIF3S9                                                                                    93973_at               eukaryotic translation initiation factor 3, subunit 9
  RPS18b                                                                                    95159_at               ribosomal protein S18b
  VALRS                                                                                     97894_at               valyl-tRNA synthetase 2
  RPL12                                                                                     160431_at              mitochondrial ribosomal protein L12
  eIF1A                                                                                     93058_at               eukaryotic translation initiation factor 1A
  eRF1                                                                                      160451_at              translation releasing factor eRF1
  eIF1A                                                                                     103708_at              eukaryotic translation initiation factor 1A
  eIF6                                                                                      94826_at               integrin beta 4 binding protein
  eRF1                                                                                      98608_at               translation releasing factor eRF1
  RPL20                                                                                     94875_at               mitochondrial ribosomal protein L20
  PHERS                                                                                     94494_at               phenylalanine-tRNA synthetase-like
  ASNS                                                                                      95133_at               asparagine synthetase
  eIF3S10                                                                                   94250_at               eukaryotic translation initiation factor 3
  NOP56                                                                                     95109_at               nucleolar protein 5A
  eIF2AS1                                                                                   94253_at               eukaryotic translation initiation factor 2A
  RRS1                                                                                      96778_at               regulator for ribosome resistance homolog (S. cerevisiae)
  eRF1                                                                                      96755_at               translation releasing factor eRF1
  eRF1                                                                                      96754_s\_at            translation releasing factor eRF1
  SUI1                                                                                      92855_at               suppressor of initiator codon mutations, related sequence 1 (*S. cerevisiae*)
  RPL11                                                                                     98876_at               mitochondrial ribosomal protein L11
  RPL52                                                                                     97443_at               mitochondrial ribosomal protein L52
  **[Figure 5E](#f5-ehp0112-001589){ref-type="fig"}---Protein folding**                                            
  CCT3                                                                                      98153_at               chaperonin subunit 3 (gamma)
  FKBP4                                                                                     92808_f\_at            FK506 binding protein 4 (59 kDa)
  CCT7                                                                                      160562_at              chaperonin subunit 7 (eta)
  PPID                                                                                      97445_at               peptidylprolyl isomerase D (cyclophilin D)
  CCT10                                                                                     92829_at               heat shock 10 kDa protein 1 (chaperonin 10)
  CCT8                                                                                      160102_at              chaperonin subunit 8 (theta)
  CCT6A                                                                                     162279_f\_at           chaperonin subunit 6a (zeta)
  CCT3                                                                                      161238_f\_at           chaperonin subunit 3 (gamma)
  **[Figure 5F](#f5-ehp0112-001589){ref-type="fig"}---Protein degradation**                                        
  PAD1                                                                                      97274_at               26S proteasome-associated pad1 homolog
  PSMB5                                                                                     101558_s\_at           proteasome (prosome, macropain) subunit, beta type 5
  PSMD4                                                                                     94302_at               proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
  PSMB3                                                                                     94025_at               proteasome (prosome, macropain) subunit, beta type 3
  SUG1                                                                                      160534_at              protease (prosome, macropain) 26S subunit, ATPase 5
  PSMB6                                                                                     101992_at              proteasome (prosome, macropain) subunit, beta type 6
  PSMB2                                                                                     94219_at               proteasome (prosome, macropain) subunit, beta type 2
  **[Figure 6B](#f6-ehp0112-001589){ref-type="fig"}---DNA replication and cell division**                          
  SAKB                                                                                      98996_at               serine/threonine kinase 18
  RRM2                                                                                      102001_at              ribonucleotide reductase M2
  CAF1 p60                                                                                  100890_at              chromatin assembly factor, p60 subunit
  ORC6                                                                                      95712_at               origin recognition complex, subunit 6-like (S. cerevisiae)
  PCNA                                                                                      101065_at              proliferating cell nuclear antigen
  MCM2                                                                                      93112_at               mini chromosome maintenance deficient 2
  CDC6                                                                                      103821_at              cell division cycle 6 homolog (S. cerevisiae)
  MCM4                                                                                      93041_at               mini chromosome maintenance deficient 4 homolog
  MCM3                                                                                      160496_s\_at           mini chromosome maintenance deficient (S. cerevisiae)
  MCM3                                                                                      100062_at              mini chromosome maintenance deficient (S. cerevisiae)
  TOPB1                                                                                     103071_at              topoisomerase (DNA) II binding protein
  CHK1                                                                                      103064_at              checkpoint kinase 1 homolog (S. pombe)
  MCM5                                                                                      100156_at              mini chromosome maintenance deficient 5
  CKS1                                                                                      97468_at               CDC28 protein kinase 1
  ORC1                                                                                      92458_at               origin recognition complex, subunit 1-like (S. cerevisiae)
  RRM1                                                                                      100612_at              ribonucleotide reductase M1
  FEN1                                                                                      97327_at               flap structure specific endonuclease 1
  GEMININ                                                                                   160069_at              geminin
  E2F1                                                                                      102963_at              E2F transcription factor 1
  PLK1                                                                                      93099_f\_at            polo-like kinase homolog (Drosophila)
  CCNB1                                                                                     160159_at              cyclin B1, related sequence 1
  **[Figure 6C](#f6-ehp0112-001589){ref-type="fig"}---Cell-cycle regulators**                                      
  CCND1                                                                                     94232_at               cyclin D1
  CDC34                                                                                     94048_at               cell division cycle 34 homolog
  KIP2                                                                                      95471_at               cyclin-dependent kinase inhibitor 1C (P57)
  CCNG2                                                                                     98478_at               cyclin G2
  KIP1                                                                                      161010_r\_at           cyclin-dependent kinase inhibitor (p27)
  CCNI                                                                                      94819_f\_at            cyclin I
  **[Figure 6D](#f6-ehp0112-001589){ref-type="fig"}---Apoptosis**                                                  
  CASP2                                                                                     99049_at               caspase 2
  NIX                                                                                       96255_at               BCL2/adenovirus E1B 19 kDa-interacting protein 3-like
  APR3                                                                                      160271_at              apoptosis related protein APR3
  TNFSF12                                                                                   93917_at               tumor necrosis factor (ligand) superfamily, member 12
  PDCD4                                                                                     103029_at              programmed cell death 4
  MIAP2                                                                                     102734_at              baculoviral IAP repeat-containing 3
  MTD                                                                                       98031_at               Bcl-2-related ovarian killer protein
  SDNSF                                                                                     97451_at               neural stem cell derived neuronal survival protein
  DAD1                                                                                      96008_at               defender against Apoptotic Death 1
  AAC11                                                                                     101035_at              apoptosis inhibitor 5
  BAG3                                                                                      96167_at               Bcl2-associated athanogene 3
  BAG2                                                                                      161129_r\_at           similar to BAG-family molecular chaperone regulator-2
  **[Figure 7A](#f7-ehp0112-001589){ref-type="fig"}---Cytoarchitecture**                                           
  MDEG2                                                                                     99910_at               amiloride-sensitive cation channel 1, neuronal (degenerin)
  MAT8                                                                                      103059_at              FXYD domain-containing ion transport regulator 3
  CLCA3                                                                                     162287_r\_at           chloride channel calcium activated 3
  CD133                                                                                     93389_at               prominin
  CD133                                                                                     93390_g\_at            prominin
  PIGF                                                                                      104725_at              ras-like protein
  DSG2                                                                                      104480_at              desmoglein 2
  MAN2B1                                                                                    99562_at               mannosidase 2, alpha B1
  CLDN4                                                                                     101410_at              claudin 4
  CLDN7                                                                                     99561_f\_at            claudin 7
  SPRR2E                                                                                    100723_f\_at           small proline-rich protein 2E
  SPRR2J                                                                                    101755_f\_at           small proline-rich protein 2J
  SPRR2A                                                                                    101025_f\_at           small proline-rich protein 2A
  TROP2                                                                                     103648_at              tumor-associated calcium signal transducer 2
  SPRR2I                                                                                    95794_f\_at            small proline-rich protein 2I
  SPRR2C                                                                                    101761_f\_at           small proline-rich protein 2C
  SPRR2A                                                                                    101024_i\_at           small proline-rich protein 2A
  LRG                                                                                       97420_at               leucine-rich alpha-2-glycoprotein
  TROP2                                                                                     160651_at              tumor-associated calcium signal transducer 2
  SPRR2G                                                                                    101754_f\_at           small proline-rich protein 2G
  SPRR2F                                                                                    94120_s\_at            small proline-rich protein 2F
  BGP1                                                                                      102805_at              CEA-related cell adhesion molecule 1
  BGP1                                                                                      102804_at              CEA-related cell adhesion molecule 1
  BGP1                                                                                      102806_g\_at           CEA-related cell adhesion molecule 1
  BGP2                                                                                      101908_s\_at           CEA-related cell adhesion molecule 2
  CX26                                                                                      98423_at               connexin 26
  MUC1                                                                                      102918_at              mucin 1, transmembrane
  SPP1                                                                                      97519_at               secreted phosphoprotein 1
  CLU                                                                                       161294_f\_at           clusterin
  CLU                                                                                       95286_at               clusterin
  CFTR                                                                                      94757_at               cystic fibrosis transmembrane conductance regulator homolog
  KRT19                                                                                     92550_at               keratin complex 1, acidic, gene 19
  KRT19                                                                                     102121_f\_at           keratin complex 1, acidic, gene 19
  SPRR1A                                                                                    160909_at              small proline-rich protein 1A
  GALNT3                                                                                    162313_f\_at           UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3
  **[Figure 7B](#f7-ehp0112-001589){ref-type="fig"}---Defense responses**                                          
  PLGR                                                                                      99926_at               polyimmunoglobulin receptor
  CTSL                                                                                      101963_at              cathepsin L
  LAMP1                                                                                     100136_at              lysosomal membrane glycoprotein 2
  CTSS                                                                                      98543_at               cathepsin S
  GSTO1                                                                                     97819_at               glutathione S-transferase omega 1
  GSTT2                                                                                     104603_at              glutathione S-transferase, theta 2
  CTSH                                                                                      94834_at               cathepsin H
  UGT1A1                                                                                    99580_s\_at            UDP glycosyltransferase 1 family, polypeptide A6
  CD14                                                                                      98088_at               CD14 antigen
  LGALS3                                                                                    95706_at               lectin, galactose binding, soluble 3
  PGLYRP                                                                                    104099_at              peptidoglycan recognition protein
  LGMN                                                                                      93261_at               legumain
  GARG16                                                                                    100981_at              interferon-induced protein with tetratricopeptide repeats
  H2Q1                                                                                      99378_f\_at            MHC beta-2-microglobulin
  ISGFG3                                                                                    103634_at              interferon dependent positive acting transcription factor 3 gamma
  H2D1                                                                                      101886_f\_at           histocompatibility 2, D region locus 1
  LYZP                                                                                      101753_s\_at           P lysozyme structural
  LYZM                                                                                      100611_at              lysozyme M
  MLGP85                                                                                    101389_at              scavenger receptor class B, member 2
  H2D1                                                                                      97540_f\_at            histocompatibility 2, D region locus 1
  CD68                                                                                      103016_s\_at           CD68 antigen
  LY6A                                                                                      93078_at               lymphocyte antigen 6 complex, locus A
  MX1                                                                                       98417_at               myxovirus (influenza virus) resistance 1
  **[Figure 7C](#f7-ehp0112-001589){ref-type="fig"}---Chemoattractant cytokines**                                  
  MCP3                                                                                      94761_at               monocyte chemoattractant protein 3
  MCP1                                                                                      102736_at              platelet-derived growth factor-inducible protein JE
  EOTAXIN                                                                                   92742_at               small inducible cytokine a11
  **[Figure 7D](#f7-ehp0112-001589){ref-type="fig"}---Complement**                                                 
  CFI                                                                                       99927_at               complement component factor i
  C3                                                                                        93497_at               complement component 3
  CFH-related                                                                               92291_f\_at            complement component factor-related
  C2                                                                                        103673_at              complement component 2 (within H-2S)
  CFH-related                                                                               101853_f\_at           complement component factor h
  C1QA                                                                                      98562_at               complement component 1, q subcomponent, alpha polypeptide
  C1QB                                                                                      96020_at               complement component 1, q subcomponent, beta polypeptide
  C4                                                                                        103033_at              complement component 4 (within H-2S)
  C1QC                                                                                      92223_at               complement component 1, q subcomponent, c polypeptide
  CFH-related                                                                               94743_f\_at            complement component factor-related
  **[Figure 7E](#f7-ehp0112-001589){ref-type="fig"}---Iron homeostasis**                                           
  CP                                                                                        92851_at               ceruloplasmin
  LTF                                                                                       101115_at              lactotransferrin
  LCN2                                                                                      160564_at              lipocalin 2/24p3 gene.
  **[Figure 8B](#f8-ehp0112-001589){ref-type="fig"}**                                                              
  ETS2                                                                                      94246_at               E26 avian leukemia oncogene 2, 3' domain
  ATF3                                                                                      104155_f\_at           activating transcription factor 3
  JUN                                                                                       100130_at              Jun oncogene
  JUNB                                                                                      102362_i\_at           transcription factor junB
  FOS                                                                                       160901_at              c-fos oncogene
  FOSB                                                                                      103990_at              FBJ osteosarcoma oncogene B
  ATF5                                                                                      103006_at              activating transcription factor 5
  ATF4                                                                                      100599_at              activating transcription factor 4
  SPRR2I                                                                                    95794_f\_at            small proline-rich protein 2I
  SPRR2C                                                                                    101761_f\_at           small proline-rich protein 2C
  SPRR2G                                                                                    101754_f\_at           small proline-rich protein 2G
  SPRR2J                                                                                    101755_f\_at           small proline-rich protein 2J
  SPRR2A                                                                                    101025_f\_at           small proline-rich protein 2A
  SPRR2F                                                                                    94120_s\_at            small proline-rich protein 2F
  SPRR2E                                                                                    100723_f\_at           small proline-rich protein 2E
  SPRR1A                                                                                    160909_at              small proline-rich protein 1A

Gene annotations were derived by interrogation of the NetAffx ([@b22-ehp0112-001589]) database; http://www.affymetrix.com/analysis/index.affx and by homology searching of nucleotide sequence databases (BLASTn; http://www.ncbi.nih.gov/BLAST/) using Affymetrix probe target sequences.
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